What should investors expect from 2014?

Investors expecting a repeat of double-digit returns in 2014 should be cautious.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Despite its recent setback, the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has delivered investors with enormous gains over the last year on the back of record low official interest rates and the US Federal Reserve's stimulus program.

However, investors expecting a repeat of double-digit returns in 2014 should be cautious with the tapering of the Fed's bond buying program imminent. It is unknown what impact the pending tapering will have on global equity markets.

For the year to 30 November, the benchmark index rose by around 22% but has shed 6.6% since hitting a high of 5457.3 points. In regards to the strong year, Patrick Farrell, head of Advance Asset Management and chief investment officer of BT Financial Group, said: "Valuations have been pushed and we now need to see some backfilling of earnings… If we don't see that, the market is very susceptible to a correction from these sorts of levels."

Whilst the easy gains from the share market may have already been realised, investors should consider expanding their horizons. For instance, instead of simply investing in the big four banks for their high dividend yields, investors should perhaps consider buying shares in less well-known companies such as Collection House (ASX: CLH) or TPG Telecom (ASX: TPM), which each offer attractive dividends and possess greater growth potential.

Another factor which investors must take into consideration is currency movements. The Australian dollar has remained strong compared to the US greenback in recent years, this has attracted significant foreign investment, however, a weakening of the Aussie dollar will see many foreign investors head for the exit.

Whilst that would not be such a good thing for the overall sharemarket, it would boost the earnings of companies which heavily rely on offshore sales. With analysts expecting the dollar to fall further to around US80c to US85c from its current value of just above US90c, UBS analysts are bullish on companies such as Amcor (ASX: AMC), CSL (ASX: CSL), ResMed (ASX: RMD) and Crown (ASX: CWN).

Get the full report on our top dividend stock for 2014 — FREE!

Motley Fool contributor Ryan Newman owns shares in Collection House.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »